Atopic dermatitis (AD), also known as eczema or atopic eczema (AE), is a common chronic inflammatory non-communicable skin disease that often manifests itself in flares of dry, red and itchy skin. It is not a well-understood disease. Lifetime prevalence can vary widely across the globe, ranging from 9% to 32%.
For those without direct experience, it can be challenging to understand the lengths to which cracked, itchy skin can overwhelm a person’s quality of life, as well as affect the lives of their family and caregivers.
This report will first examine the impact of AD on patients and its considerable social, financial and economic impacts. Then, we explore health strategies to address AD and the challenges patients often have in navigating their health systems. It will then look at the adoption of best practices, including integrated care, and the role patient groups in supporting patients. Finally, it will provide an outlook on the key issues for policymakers and actions they may take to improve AD care.